FDA Approves New Foolish Treatment for Allergies - My Blunt Assessment
Following is an announcement regarding a new drug to treat hay fever. After that are my comments. Be warned, they are rather blunt.
The US Food and Drug Administration (FDA) announced October 23 the approval of Omnaris (ciclesonide) nasal spray, a new drug for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis, commonly known as hay fever, in adults and children 12 years of age and older.
Although the precise way Omnaris works is unknown, the drug is a corticosteroid. Corticosteroids are hormone-like drugs that suppress the immune response.